Grupo Fisiopatología Endocrina, Nutricional y Médica
FENM
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (2)
2020
-
Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 20, Núm. 1, pp. 105-114
2019
-
Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study
Pituitary, Vol. 22, Núm. 2, pp. 137-145